Dr Ingrid Brands, General Manager

Ingrid is a serial-entrepreneur and seasoned leader with more than 2 decades of senior research and management experience under her belt.

Why we love multi-omics analysis

Dr Ingrid Brands, General Manager | December 7, 2022

The key challenge to understanding complex biological systems is that they cannot be simply decoded...

Key elements of successful AI-native drug discovery

Dr Ingrid Brands, General Manager | November 17, 2022

The use of AI in drug discovery has been progressively expanding over the past decade. Over the...

What is a biomarker?

Dr Ingrid Brands, General Manager | November 2, 2022

A biomarker, or biological marker, broadly refers to a range of objectively, accurately, and...

Precision drugs for the precision medicine era

Dr Ingrid Brands, General Manager | October 26, 2022

Currently, chemotherapy, using cytotoxic small molecules to kill cancer cells, is the predominant...

What is precision medicine?

Dr Ingrid Brands, General Manager | October 12, 2022

In 1999, an innovative collaboration between 10 of the world’s largest pharmaceutical companies,...

Subscribe to our blog

The role of NGS in breast cancer diagnosis and treatment

Dr Ingrid Brands, General Manager | October 6, 2022

Breast cancer is the most common cancer in women worldwide, accounting for 25% of all female...

A brief retrospective on our second blogiversary

Dr Ingrid Brands, General Manager | September 21, 2022

It’s been an eventful two years, to the month, since we launched our omics and analysis blog. Our...

AI in Biopharma: Challenges and Opportunities

Dr Ingrid Brands, General Manager | September 14, 2022

There are an estimated novemdecillion, or 1060, molecules in the known universe with potential...

Accelerate Biomarker Discovery with Artificial Intelligence

Dr Ingrid Brands, General Manager | August 31, 2022

Biomarkers play a critical role in realizing the true potential of precision medicine. As accurate...

Top 4 challenges of equitable precision medicine

Dr Ingrid Brands, General Manager | August 25, 2022

In our previous articles on precision medicine, we reviewed how advances in precision medicine...

Closing the Gap of Text and the Biosphere with LENSai™ NLP Link

Dr Ingrid Brands, General Manager | August 17, 2022

Bridging the gap between raw sequence data, secondary research, experimental data, and the...